Alector (ALEC) Operating Income (2018 - 2026)
Alector (ALEC) reported Operating Income of -$24.9 million for Q1 2026, up 44.25% year-over-year from -$17.3 million in Q1 2025, and down 128.82% quarter-over-quarter from $86.5 million in Q4 2025.
Alector (ALEC) Operating Income (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Operating Income data on file, last reported at -$24.9 million in Q1 2026.
- Operating Income for Q1 2026 came in at -$24.9 million, up 44.25% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.2 million (up 93.01% YoY), and the FY2025 annual result was -$30.0 million, up 79.32% from the prior year.
- Operating Income fell to -$24.9 million in Q1 2026 per ALEC's latest filing, from $86.5 million in the prior quarter.
- Over five years, Operating Income peaked at $86.5 million in Q4 2025 and troughed at -$55.4 million in Q4 2022.
- A 5-year average of -$21.4 million and a median of -$43.7 million in 2024 frame the typical range for Operating Income.
- The sharpest annual moves came in 2024 and 2025: Operating Income tumbled 1170.72% in 2024, then surged 1292.73% in 2025.
- A 5-year view of Operating Income shows it stood at -$55.4 million in 2022, then surged by 240.88% to $78.1 million in 2023, then tumbled by 109.28% to -$7.2 million in 2024, then surged by 1292.73% to $86.5 million in 2025, then sank by 128.82% to -$24.9 million in 2026.
- Business Quant data shows ALEC's Operating Income at -$24.9 million in Q1 2026, $86.5 million in Q4 2025, and -$37.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | -24.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.92 Mn |
| Dec 31, 2025 | 86.46 Mn |
| Sep 30, 2025 | -37.61 Mn |
| Jun 30, 2025 | -34.14 Mn |
| Mar 31, 2025 | -44.70 Mn |
| Dec 31, 2024 | -7.25 Mn |
| Sep 30, 2024 | -48.43 Mn |
| Jun 30, 2024 | -45.61 Mn |
| Mar 31, 2024 | -43.71 Mn |
| Dec 31, 2023 | 78.10 Mn |
| Sep 30, 2023 | -50.58 Mn |
| Jun 30, 2023 | -3.59 Mn |
| Mar 31, 2023 | -50.12 Mn |
| Dec 31, 2022 | -55.44 Mn |
| Sep 30, 2022 | -47.75 Mn |
| Jun 30, 2022 | 9.48 Mn |
| Mar 31, 2022 | -44.12 Mn |
| Dec 31, 2021 | -26.00 Mn |
| Sep 30, 2021 | 126.33 Mn |
| Jun 30, 2021 | -55.33 Mn |